SNT207858 free base is a selective, blood brain barrier penetrating, potent and orally active melanocortin-4 ( MC-4 ) receptor antagonist. SNT207858 free base has an IC 50 of 22 nM (binding) and 11 nM (function) on the MC-4 receptor
In Vitro
SNT207858 binds to the MC-4 receptor with an affinity of 22 nM and shows a 170-fold selectivity vs. MC-3 and a 40-fold selectivity vs. MC-5. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
SNT207858 (30 mg/kg; oral administration; once daily; 15 days) significantly reduces the tumor induced weight loss in mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Mice with C26 adenocarcinoma-induced cachexia model Dosage: 30 mg/kg Administration: Oral administration; once daily; 15 days Result: Significantly reduced the tumor induced weight loss.
Form:Solid
IC50& Target:MC-4 receptor
规格
别名
SNT-207858 游离碱
规格或纯度
≥99%
英文名称
SNT-207858 free base
生化机理
SNT207858 游离碱是一种具有选择性、血脑屏障穿透性、强效和口服活性的黑色素皮质素-4(MC-4)受体拮抗剂。SNT207858 free base 对 MC-4 受体的 IC 50 值为 22 nM(结合)和 11 nM(功能)。